Enzon Pharmaceuticals Inc (ENZN)
0.075
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Enzon Pharmaceuticals Price to Book Value: 1.588 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.588 |
| May 02, 2024 | 1.588 |
| May 01, 2024 | 1.796 |
| April 30, 2024 | 1.767 |
| April 29, 2024 | 1.767 |
| April 26, 2024 | 1.767 |
| April 25, 2024 | 1.863 |
| April 24, 2024 | 1.651 |
| April 23, 2024 | 1.651 |
| April 22, 2024 | 1.532 |
| April 19, 2024 | 1.532 |
| April 18, 2024 | 1.532 |
| April 17, 2024 | 1.532 |
| April 16, 2024 | 1.372 |
| April 15, 2024 | 1.584 |
| April 12, 2024 | 2.007 |
| April 11, 2024 | 2.007 |
| April 10, 2024 | 2.007 |
| April 09, 2024 | 1.955 |
| April 08, 2024 | 1.688 |
| April 05, 2024 | 1.482 |
| April 04, 2024 | 1.482 |
| April 03, 2024 | 1.376 |
| April 02, 2024 | 1.313 |
| April 01, 2024 | 1.657 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.001 |
| March 27, 2024 | 2.001 |
| March 26, 2024 | 1.789 |
| March 25, 2024 | 1.524 |
| March 22, 2024 | 1.482 |
| March 21, 2024 | 1.694 |
| March 20, 2024 | 1.482 |
| March 19, 2024 | 1.270 |
| March 18, 2024 | 1.753 |
| March 15, 2024 | 1.753 |
| March 14, 2024 | 1.753 |
| March 13, 2024 | 1.769 |
| March 12, 2024 | 1.800 |
| March 11, 2024 | 1.482 |
| March 08, 2024 | 1.482 |
| March 07, 2024 | 1.699 |
| March 06, 2024 | 1.643 |
| March 05, 2024 | 1.753 |
| March 04, 2024 | 1.378 |
| March 01, 2024 | 1.643 |
| February 29, 2024 | 1.383 |
| February 28, 2024 | 1.459 |
| February 27, 2024 | 1.694 |
| February 26, 2024 | 1.800 |
| February 23, 2024 | 1.800 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8127
Minimum
May 14 2019
10.04
Maximum
Aug 08 2022
3.911
Average
4.119
Median
Sep 23 2021
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.116 |
| Perspective Therapeutics Inc | 14.13 |
| Protalix BioTherapeutics Inc | 2.481 |
| Electromed Inc | 3.946 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price to Free Cash Flow | 4.265 |
| Price | 0.075 |
| Earnings Yield | -0.93% |
| Market Cap | 5.566M |